K. Althaus and A. Greinacher, MYH9-related platelet disorders, Semin Thromb Hemost, vol.35, pp.189-203, 2009.

R. Hegglin, Gleichzeitige konstitutionelle Veranderungen an Neutrophilen und Thrombozyten, Helv Med Acta, vol.12, p.439, 1945.

J. M. Lusher, J. Schneider, and I. Mizukami, The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies, Blood, vol.32, pp.950-961, 1968.

C. J. Epstein, M. A. Sahud, and C. F. Piel, Hereditary macrothrombocytopathia, nephritis and deafness, Am J Med, vol.52, pp.299-310, 1972.

L. C. Peterson, K. V. Rao, and J. T. Crosson, Fechtner syndrome-a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia, Blood, vol.65, pp.397-406, 1985.

A. Greinacher, H. K. Nieuwenhuis, and J. G. White, Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions, Blut, vol.61, pp.282-288, 1990.

M. Seri, R. Cusano, and S. Gangarossa, Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium, Nat Genet, vol.26, pp.103-105, 2000.

K. E. Heath, A. Campos-barros, and A. Toren, Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes, Am J Hum Genet, vol.69, pp.1033-1045, 2001.

B. Saposnik, S. Binard, and O. Fenneteau, Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders, Mol Genet Genomic Med, vol.2, pp.297-312, 2014.

A. Pecci, C. Klersy, and P. Gresele, MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations, Hum Mutat, vol.35, pp.236-247, 2014.

A. Pecci, E. Panza, and N. Pujol-moix, Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease, Hum Mutat, vol.29, pp.409-417, 2008.

T. Sekine, M. Konno, and S. Sasaki, Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease, Kidney Int, vol.78, pp.207-214, 2010.

K. H. Han, H. K. Lee, and H. G. Kang, Renal manifestations of patients with MYH9-related disorders, Pediatr Nephrol Berl Ger, vol.26, pp.549-555, 2011.

S. Kunishima, T. Kojima, and T. Matsushita, Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/ Sebastian syndrome), Blood, vol.97, pp.1147-1149, 2001.

D. Vassallo, I. Erekosima, and D. Kanigicherla, Myosin heavy chain-9-related disorders (MYH9-RD): a case report, Clin Kidney J, vol.6, pp.516-518, 2013.

J. B. Kopp, Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?, Kidney Int, vol.78, pp.130-133, 2010.

N. M. Clare, M. M. Montiel, and M. D. Lifschitz, Alport's syndrome associated with macrothrombopathic thrombocytopenia, Am J Clin Pathol, vol.72, pp.111-117, 1979.

S. Tú-ri, J. Kó-bor, and . Erd}, Hereditary nephritis, platelet disorders and deafness-Epstein's syndrome, Pediatr Nephrol, vol.6, pp.38-43, 1992.

H. Iyori, A. Tokushige, and N. Ishitoya,

, Nihon Jinzo Gakkai Shi, vol.37, pp.62-68, 1995.

M. M. Moxey-mims, G. Young, and A. Silverman, End-stage renal disease in two pediatric patients with Fechtner syndrome, Pediatr Nephrol, vol.13, pp.782-786, 1999.

I. Naito, S. Nomura, and S. Inoue, Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome, J Clin Pathol, vol.50, pp.919-922, 1997.

G. M. Ghiggeri, G. Caridi, and U. Magrini, Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome)

, Am J Kidney Dis, vol.41, pp.95-104, 2003.

E. Alhindawi, A. , and S. , Epstein syndrome with rapid progression to end stage renal disease, Saudi J Kidney Dis Transplant, vol.20, pp.1076-1078, 2009.

D. Yap, K. C. Tse, and T. M. Chan, Epstein syndrome presenting as renal failure in young patients, Ren Fail, vol.31, pp.582-585, 2009.

J. Hao, S. Kunishima, and X. Guo, A large family with MYH9 disorder caused by E1841K mutation suffering from serious kidney and hearing impairment and cataracts, Ann Hematol, vol.91, pp.1147-1148, 2012.

X. Sun, Z. Wang, Y. , and H. , Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease, Acta Haematol, vol.129, pp.106-113, 2013.

S. Y. Min, H. J. Ahn, and W. S. Park, Successful renal transplantation in MYH9-related disorder with severe macrothrombocytopenia: first report in Korea, Transplant Proc, vol.46, pp.654-656, 2014.

T. Oh, J. Seo, H. , T. Lee, and K. , Kidney Res Clin Pract, vol.34, pp.53-56, 2015.

C. Gast, R. J. Pengelly, and M. Lyon, COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis, Nephrol Dial Transplant, vol.31, pp.961-970, 2016.

C. Pescucci, F. Mari, and I. Longo, Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene, Kidney Int, vol.65, pp.1598-1603, 2004.

M. Seri, A. Pecci, D. Bari, and F. , MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness, Medicine (Baltimore), vol.82, pp.203-215, 2003.

F. Fabbian, F. Ricci, D. Giorgi, and A. , The May-Hegglin anomaly in a kidney transplant recipient, NDT Plus, vol.3, p.312, 2010.

N. Nel, B. W. Van-rensburg, and L. Du-plessis, Coincidental finding of May-Hegglin anomaly in a patient with end-stage renal failure, Am J Hematol, vol.40, pp.216-221, 1992.

J. Demeter, G. Lelkes, and L. Nemes, Familial occurrence of the May-Hegglin anomaly: is the accompanying renal failure part of a new subentity, Ann Hematol, vol.80, pp.368-371, 2001.

G. Sevignani, G. M. Pavanelli, and S. S. Milano,

. Macrothrombocytopenia, renal dysfunction and nephrotic syndrome in a young male patient: a case report of MYH9-related disease, J Bras Nefrol, vol.40, pp.198-200, 2018.

K. A. Nath, Tubulointerstitial changes as a major determinant in the progression of renal damage, Am J Kidney Dis, vol.20, pp.1-17, 1992.

A. Srivastava, R. Palsson, and A. D. Kaze, The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston Kidney Biopsy Cohort Study, J Am Soc Nephrol, vol.29, pp.2213-2224, 2018.

J. G. Drachman, Inherited thrombocytopenia: when a low platelet count does not mean ITP, Blood, vol.103, pp.390-398, 2004.

R. A. Shivdasani and . My, and platelets, too, Blood, vol.110, p.3093, 2007.

C. Lé-on, A. Eckly, and B. Hechler, Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion, Blood, vol.110, pp.3183-3191, 2007.

A. Pecci, P. Gresele, and C. Klersy, Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations, Blood, vol.116, pp.5832-5837, 2010.

C. L. Balduini, P. Noris, and S. Belletti, In vitro and in vivo effects of desmopressin on platelet function, Haematologica, vol.84, pp.891-896, 1999.

C. Lé-on, K. Evert, and F. Dombrowski, Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD, Blood, vol.119, pp.3333-3341, 2012.

A. Pecci, G. Biino, and T. Fierro, Alteration of liver enzymes is a feature of the MYH9-related disease syndrome, PloS One, vol.7, p.35986, 2012.

D. B. Johnstone, J. Zhang, and B. George, Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy, Mol Cell Biol, vol.31, pp.2162-2170, 2011.

C. Arrondel, N. Vodovar, and B. Knebelmann, Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes, J Am Soc Nephrol, vol.13, pp.65-74, 2002.

Y. Huang, H. Shi, and H. Zhou, The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin, Blood, vol.107, pp.3564-3571, 2006.

Y. Zhang, M. A. Conti, and D. Malide, Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A, Blood, vol.119, pp.238-250, 2012.